MERCK & CO. INC.
MRKNYSE🏆 #34 by market capEarnings Feb 2 · PreUS Equity
$133.70—
Last available close · quote unavailableTrack MRK
Get earnings, price moves & breaking news on Telegram
24h—
7d▼ 9.5%
14d▼ 8.9%
30d▼ 8.0%
ytd▲ 27.0%
1y▲ 36.8%
🏦Market Cap
$329.65B
Large Cap
📈Revenue Growth (YoY)
4.9%
Slowing
📊Gross Margin
76.6%
High
💵FCF Margin
21.9%
Strong
⚖️P/S Ratio
4.9x
Fair
Otter Score
72
Strong
MERCK & CO. INC.
MRKAnalyst Ratings
Price
$133.70
Total
20
Raised
17
Lowered
2
Avg PT
$162.15
H / L
$180 / $138
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Barclays Merck & Co | Raised | Overweight | 2026-10-26 | $180.00 | +34.60% |
Scotiabank Merck & Co | Raised | Sector Outperform | 2026-09-29 | $180.00 | +34.60% |
Wolfe Research Merck & Co | Raised | Outperform | 2026-08-25 | $180.00 | +34.60% |
Morgan Stanley Merck & Co | Lowered | Overweight | 2026-10-07 | $177.00 | +32.40% |
JP Morgan Merck & Co | Raised | Overweight | 2026-10-30 | $175.00 | +30.90% |
UBS Merck & Co | Raised | Buy | 2026-08-20 | $175.00 | +30.90% |
HSBC Merck & Co | Raised | Buy | 2026-09-10 | $172.00 | +28.60% |
Guggenheim Merck & Co | Raised | Buy | 2026-10-30 | $171.00 | +27.90% |
Wells Fargo Merck & Co | Raised | Overweight | 2026-09-04 | $170.00 | +27.20% |
Argus Research Merck & Co | Raised | Buy | 2026-08-25 | $170.00 | +27.20% |
BMO Capital Merck & Co | Raised | Outperform | 2026-08-20 | $170.00 | +27.20% |
Leerink Partners Merck & Co | Raised | Outperform | 2026-09-09 | $161.00 | +20.40% |
Goldman Sachs Merck & Co | Raised | Buy | 2026-08-21 | $160.00 | +19.70% |
Cantor Fitzgerald Merck & Co | Raised | Neutral | 2026-11-02 | $155.00 | +15.90% |
Citigroup Merck & Co | Raised | Neutral | 2026-10-12 | $145.00 | +8.50% |
Daiwa Capital Merck & Co | Raised | Neutral → Outperform | 2026-08-12 | $143.00 | +7.00% |
B of A Securities Merck & Co | Raised | Buy | 2026-06-30 | $141.00 | +5.50% |
Freedom Broker Merck & Co | Raised | Hold | 2026-11-02 | $140.00 | +4.70% |
RBC Capital Merck & Co | Lowered | Sector Perform | 2026-10-30 | $140.00 | +4.70% |
CICC Merck & Co | Initiated | Outperform | 2026-06-24 | $138.00 | +3.20% |
Institution
Barclays
Raised · Overweight · 2026-10-26
$180.00
+34.60%
Scotiabank
Raised · Sector Outperform · 2026-09-29
$180.00
+34.60%
Wolfe Research
Raised · Outperform · 2026-08-25
$180.00
+34.60%
Morgan Stanley
Lowered · Overweight · 2026-10-07
$177.00
+32.40%
JP Morgan
Raised · Overweight · 2026-10-30
$175.00
+30.90%
UBS
Raised · Buy · 2026-08-20
$175.00
+30.90%
HSBC
Raised · Buy · 2026-09-10
$172.00
+28.60%
Guggenheim
Raised · Buy · 2026-10-30
$171.00
+27.90%
Wells Fargo
Raised · Overweight · 2026-09-04
$170.00
+27.20%
Argus Research
Raised · Buy · 2026-08-25
$170.00
+27.20%
BMO Capital
Raised · Outperform · 2026-08-20
$170.00
+27.20%
Leerink Partners
Raised · Outperform · 2026-09-09
$161.00
+20.40%
Goldman Sachs
Raised · Buy · 2026-08-21
$160.00
+19.70%
Cantor Fitzgerald
Raised · Neutral · 2026-11-02
$155.00
+15.90%
Citigroup
Raised · Neutral · 2026-10-12
$145.00
+8.50%
Daiwa Capital
Raised · Neutral → Outperform · 2026-08-12
$143.00
+7.00%
B of A Securities
Raised · Buy · 2026-06-30
$141.00
+5.50%
Freedom Broker
Raised · Hold · 2026-11-02
$140.00
+4.70%
RBC Capital
Lowered · Sector Perform · 2026-10-30
$140.00
+4.70%
CICC
Initiated · Outperform · 2026-06-24
$138.00
+3.20%
One row per institution · price target from the firm's latest published target